SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS
The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DADEY, ERIC |
| description | The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite, or a prodrug thereof.
L'invention concerne un système d'administration à libération prolongée de rispéridone pour le traitement d'états médicaux en rapport avec la psychose délirante, la schizophrénie, les troubles bipolaires, la dépression psychotique, les troubles obsessionnels compulsifs, le syndrome de Gilles de la Tourette, et les troubles du spectre autistique. Le système d'administration à libération prolongée comprend une composition liquide contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci et un implant contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci. La composition liquide peut être injectée dans le tissu où il coagule pour devenir l'implant monolithique solide ou gélifié. La composition liquide comprend un polymère thermoplastique biodégradable, un liquide organique et de la rispéridone, un métabolite, ou un promédicament de celle-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2687979C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2687979C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2687979C3</originalsourceid><addsrcrecordid>eNrjZLAIDg0OcfT0c3VRcHH18QxzDYpUcPMP8g31cQzx9PcLVvB3UwjyDA5wDfJ08fdzVXD29w3wD_VzCeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjkZmFuaW5pbOxoRVAAAKUChN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS</title><source>esp@cenet</source><creator>DADEY, ERIC</creator><creatorcontrib>DADEY, ERIC</creatorcontrib><description>The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite, or a prodrug thereof.
L'invention concerne un système d'administration à libération prolongée de rispéridone pour le traitement d'états médicaux en rapport avec la psychose délirante, la schizophrénie, les troubles bipolaires, la dépression psychotique, les troubles obsessionnels compulsifs, le syndrome de Gilles de la Tourette, et les troubles du spectre autistique. Le système d'administration à libération prolongée comprend une composition liquide contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci et un implant contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci. La composition liquide peut être injectée dans le tissu où il coagule pour devenir l'implant monolithique solide ou gélifié. La composition liquide comprend un polymère thermoplastique biodégradable, un liquide organique et de la rispéridone, un métabolite, ou un promédicament de celle-ci.</description><language>eng ; fre</language><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES ; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR ; HUMAN NECESSITIES ; HYGIENE ; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES ; MEDICAL OR VETERINARY SCIENCE ; METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170704&DB=EPODOC&CC=CA&NR=2687979C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170704&DB=EPODOC&CC=CA&NR=2687979C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DADEY, ERIC</creatorcontrib><title>SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS</title><description>The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite, or a prodrug thereof.
L'invention concerne un système d'administration à libération prolongée de rispéridone pour le traitement d'états médicaux en rapport avec la psychose délirante, la schizophrénie, les troubles bipolaires, la dépression psychotique, les troubles obsessionnels compulsifs, le syndrome de Gilles de la Tourette, et les troubles du spectre autistique. Le système d'administration à libération prolongée comprend une composition liquide contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci et un implant contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci. La composition liquide peut être injectée dans le tissu où il coagule pour devenir l'implant monolithique solide ou gélifié. La composition liquide comprend un polymère thermoplastique biodégradable, un liquide organique et de la rispéridone, un métabolite, ou un promédicament de celle-ci.</description><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</subject><subject>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAIDg0OcfT0c3VRcHH18QxzDYpUcPMP8g31cQzx9PcLVvB3UwjyDA5wDfJ08fdzVXD29w3wD_VzCeZhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfHOjkZmFuaW5pbOxoRVAAAKUChN</recordid><startdate>20170704</startdate><enddate>20170704</enddate><creator>DADEY, ERIC</creator><scope>EVB</scope></search><sort><creationdate>20170704</creationdate><title>SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS</title><author>DADEY, ERIC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2687979C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2017</creationdate><topic>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</topic><topic>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DADEY, ERIC</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DADEY, ERIC</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS</title><date>2017-07-04</date><risdate>2017</risdate><abstract>The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating delusional psychosis, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsion disorder, Tourette syndrome, and autistic spectrum disorders. The sustained release delivery system includes a flowable composition containing risperidone, a metabolite, or a prodrug thereof and an implant containing risperidone, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, an organic liquid, and risperidone, a metabolite, or a prodrug thereof.
L'invention concerne un système d'administration à libération prolongée de rispéridone pour le traitement d'états médicaux en rapport avec la psychose délirante, la schizophrénie, les troubles bipolaires, la dépression psychotique, les troubles obsessionnels compulsifs, le syndrome de Gilles de la Tourette, et les troubles du spectre autistique. Le système d'administration à libération prolongée comprend une composition liquide contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci et un implant contenant de la rispéridone, un métabolite, ou un promédicament de celle-ci. La composition liquide peut être injectée dans le tissu où il coagule pour devenir l'implant monolithique solide ou gélifié. La composition liquide comprend un polymère thermoplastique biodégradable, un liquide organique et de la rispéridone, un métabolite, ou un promédicament de celle-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2687979C |
| source | esp@cenet |
| subjects | CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES DISINFECTION, STERILISATION, OR DEODORISATION OF AIR HUMAN NECESSITIES HYGIENE MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES MEDICAL OR VETERINARY SCIENCE METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUNDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A32%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DADEY,%20ERIC&rft.date=2017-07-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2687979C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |